Your browser doesn't support javascript.
loading
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency.
Papiris, S A; Veith, M; Lazaratou, A; Balduyck, M; Lombard, C; Dechomet, M; Odou, M-F; Entrena, E; Osaba, L; Kallieri, M; Apollonatou, V; Prountzos, S; Kontopoulou, C; Kolilekas, L; Ferrarotti, I; Mornex, J-F; Vogelmeier, C-F; Greulich, T; Manali, E D.
Afiliação
  • Papiris SA; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Veith M; Department of Medicine, Pulmonary and Critical Care Medicine, UKGM, Member of the German Center for Lung Research (DZL), Marburg, Germany.
  • Lazaratou A; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Balduyck M; CHU de Lille, laboratoire de biochimie et biologie moléculaire (HMNO), centre de biologie pathologie, Faculté de pharmacie et EA 7364 RADEME, laboratoire de biochimie et biologie moléculaire, Université de Lille, Lille, France.
  • Lombard C; Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon & Université Claude Bernard-Lyon 1, Lyon, France.
  • Dechomet M; Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon & Université Claude Bernard-Lyon 1, Lyon, France.
  • Odou MF; CHU Lille, Service de Biochimie et Biologie moléculaire 'Hormonologie, Métabolisme-Nutrition, Oncologie', Univ. Lille, Inserm, U1286 - Infinite, F-59000 Lille, France.
  • Entrena E; Progenika Biopharma, a Grifols Company, Derio, Vizcaya, Spain.
  • Osaba L; Progenika Biopharma, a Grifols Company, Derio, Vizcaya, Spain.
  • Kallieri M; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Apollonatou V; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Prountzos S; 2nd Department of Radiology, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Kontopoulou C; 2nd Department of Radiology, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
  • Kolilekas L; 7thPulmonary Department, Athens Chest Hospital "Sotiria", Athens Greece.
  • Ferrarotti I; Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency, Department of Internal Medicine and Therapeutics, Pneumonology Unit, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
  • Mornex JF; Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, Hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, UMR754 INRA, IVPC, Lyon, France.
  • Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, UKGM, Member of the German Center for Lung Research (DZL), Marburg, Germany.
  • Greulich T; Department of Medicine, Pulmonary and Critical Care Medicine, UKGM, Member of the German Center for Lung Research (DZL), Marburg, Germany.
  • Manali ED; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece. Electronic address: fmanali@otenet.gr.
Pulmonology ; 29(6): 564-567, 2023.
Article em En | MEDLINE | ID: mdl-37263862

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiência de alfa 1-Antitripsina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiência de alfa 1-Antitripsina Idioma: En Ano de publicação: 2023 Tipo de documento: Article